Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Dec-22 9:48 PM View:  | Lord Jonathan T Md Director | Biolase Technology, Inc. (BIOL) | 07-Dec-22 | Private Sale | 3,537 | $0.75 | $2,652.75 | (6%) 63.46K to 59.92K | |
| 02-May-22 1:44 PM View: | Beaver John R President & CEO Director | Biolase Technology, Inc. (BIOL) | 28-Apr-22 | Disposition | 555 | -- | -- | (100%) 0.55K to 0 | |
| 02-May-22 1:48 PM View: | Lord Jonathan T Md Director | Biolase Technology, Inc. (BIOL) | 28-Apr-22 | Disposition | 1,395 | -- | -- | (100%) 1.4K to 0 | |
| 02-May-22 1:45 PM View: | Roper Jess Director | Biolase Technology, Inc. (BIOL) | 28-Apr-22 | Disposition | 346 | -- | -- | (100%) 0.34K to 0 | |
| 16-Dec-21 6:38 PM View: | Lord Jonathan T Md Director | Biolase Technology, Inc. (BIOL) | 15-Dec-21 | Sale | 11,038 | $0.38 | $4,194.44 | (2%) 644.13K to 633.1K | |
| 02-Dec-21 5:27 PM View: | Beaver John R President & CEO Director | Biolase Technology, Inc. (BIOL) | 30-Nov-21 | Private Purchase | 70,000 | $0.45 | $31,500.00 | 13% 551.53K to 621.53K | |
| 23-Aug-21 10:11 AM View: | Beaver John R President & CEO Director | Biolase Technology, Inc. (BIOL) | 20-Aug-21 | Market Purchase | 35,000 | $0.61 | $21,350.00 | 7% 516.53K to 551.53K | 2% |
| 19-May-21 2:19 PM View: | Beaver John R President & CEO Director | Biolase Technology, Inc. (BIOL) | 19-May-21 | Market Purchase | 40,000 | $0.75 | $30,000.00 | 8% 476.53K to 516.53K | (< 1%) |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 18-Dec-20 | Market Sale | 187,774 | $0.28 | $52,576.70 | (3%) 5.71M to 5.52M | (129%) |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 17-Dec-20 | Market Sale | 572,671 | $0.28 | $160,348.00 | (9%) 6.28M to 5.71M | (136%) |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 16-Dec-20 | Market Sale | 90,575 | $0.28 | $25,361.00 | (1%) 6.37M to 6.28M | (130%) |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 04-Dec-20 | Market Sale | 1,200,000 | $0.30 | $360,000.00 | (16%) 7.57M to 6.37M | (103%) |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 30-Nov-20 | Market Sale | 1,115,000 | $0.30 | $334,500.00 | (13%) 8.69M to 7.57M | (106%) |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 25-Nov-20 | Market Sale | 203,057 | $0.29 | $58,886.50 | (2%) 8.89M to 8.69M | (117%) |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 24-Nov-20 | Market Sale | 71,100 | $0.30 | $21,330.00 | (< 1%) 8.96M to 8.89M | (100%) |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 28-Jul-20 | Conversion | 3,745,000 | $0.40 | $1,498,000.00 | 72% 5.22M to 8.96M | 30% |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 10-Jun-20 | Market Sale | 1,733,840 | $0.55 | $953,610.00 | (25%) 6.95M to 5.22M | 3% |
| 10-Jun-20 5:05 PM View: | Feinberg Larry N 10% Owner | Biolase Technology, Inc. (BIOL) | 09-Jun-20 | Market Sale | 1,770,310 | $0.55 | $976,010.00 | (30%) 5.98M to 4.21M | (9%) |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 09-Jun-20 | Market Sale | 2,137,560 | $0.54 | $1,154,280.00 | (24%) 9.09M to 6.95M | < 1% |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 08-Jun-20 | Market Sale | 1,847,650 | $0.55 | $1,016,210.00 | (17%) 10.94M to 9.09M | 3% |
| 10-Jun-20 5:05 PM View: | Feinberg Larry N 10% Owner | Biolase Technology, Inc. (BIOL) | 08-Jun-20 | Market Sale | 3,402,940 | $0.55 | $1,885,910.00 | (36%) 9.39M to 5.98M | (8%) |
| 26-May-23 1:13 PM View: | Schuler Family Foundation 10% Owner | Biolase Technology, Inc. (BIOL) | 11-Feb-20 | Market Purchase | 1,307,930 | $0.61 | $797,838.00 | 14% 9.63M to 10.94M | (11%) |
| 15-May-20 4:30 PM View: | Schuler Jack W 10% Owner | Biolase Technology, Inc. (BIOL) | 11-Feb-20 | Market Sale | 1,307,930 | $0.60 | $784,759.00 | (63%) 2.07M to 759.82K | (1%) |
| 31-Oct-19 9:21 PM View: | Feinberg Larry N 10% Owner | Biolase Technology, Inc. (BIOL) | 29-Oct-19 | Purchase | 17,391 | $57.50 | $999,982.00 | 100% 0 to 17.39K | |
| 27-Aug-19 2:33 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 23-Aug-19 | Payment of Exercise | 2,903 | $1.20 | $3,487.92 | (3%) 112.03K to 109.12K | 51% |
| 22-Aug-19 6:45 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 22-Aug-19 | Payment of Exercise | 8,102 | $1.22 | $9,884.44 | (7%) 120.13K to 112.03K | 51% |
| 22-Aug-19 6:45 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 21-Aug-19 | Payment of Exercise | 5,443 | $1.20 | $6,544.46 | (4%) 125.57K to 120.13K | 51% |
| 22-Aug-19 6:45 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 20-Aug-19 | Payment of Exercise | 12,605 | $1.22 | $15,378.10 | (9%) 138.18K to 125.57K | 51% |
| 19-Aug-19 9:52 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 19-Aug-19 | Payment of Exercise | 4,323 | $1.22 | $5,274.06 | (3%) 142.5K to 138.18K | 51% |
| 19-Aug-19 9:52 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 16-Aug-19 | Payment of Exercise | 37 | $1.25 | $46.25 | (< 1%) 142.54K to 142.5K | 53% |
| 19-Aug-19 9:52 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 15-Aug-19 | Payment of Exercise | 7,715 | $1.30 | $10,029.50 | (5%) 150.25K to 142.54K | 54% |
| 27-Jun-19 4:31 PM View: | Feinberg Larry N 10% Owner | Biolase Technology, Inc. (BIOL) | 25-Jun-19 | Market Sale | 1,000,000 | $1.50 | $1,500,000.00 | (16%) 6.17M to 5.17M | 61% |
| 05-Jun-19 7:32 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 04-Jun-19 | Payment of Exercise | 948 | $1.60 | $1,516.80 | (3%) 34.53K to 33.59K | 63% |
| 05-Jun-19 7:32 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 03-Jun-19 | Payment of Exercise | 4,446 | $1.52 | $6,757.92 | (11%) 38.98K to 34.53K | 61% |
| 03-Jun-19 5:18 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 31-May-19 | Payment of Exercise | 30,094 | $1.55 | $46,645.70 | (44%) 69.07K to 38.98K | 62% |
| 03-Jun-19 5:18 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 30-May-19 | Payment of Exercise | 17,594 | $1.78 | $31,317.30 | (20%) 86.67K to 69.07K | 67% |
| 14-Dec-18 7:15 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 13-Dec-18 | Market Purchase | 10,000 | $1.03 | $10,319.00 | 200% 5.0K to 15.0K | (43%) |
| 14-Dec-18 9:07 PM View: | Sato Garrett Director | Biolase Technology, Inc. (BIOL) | 13-Dec-18 | Market Purchase | 5,000 | $1.07 | $5,350.00 | 50% 10.0K to 15.0K | (45%) |
| 14-Dec-18 7:15 PM View: | Norbe Todd President and CEO Director | Biolase Technology, Inc. (BIOL) | 12-Dec-18 | Market Purchase | 5,000 | $1.03 | $5,150.00 | 100% 0 to 5.0K | (42%) |
| 06-Dec-18 10:20 AM View: | Beaver John R EVP & Chief Financial Officer | Biolase Technology, Inc. (BIOL) | 03-Dec-18 | Market Purchase | 1,000 | $1.18 | $1,180.00 | 4% 25.0K to 26.0K | (50%) |
| 30-Nov-18 10:27 AM View: | Sato Garrett Director | Biolase Technology, Inc. (BIOL) | 29-Nov-18 | Market Purchase | 5,000 | $1.22 | $6,100.00 | 100% 5.0K to 10.0K | (51%) |
| 20-Nov-18 7:54 PM View: | Lord Jonathan T Md Director | Biolase Technology, Inc. (BIOL) | 16-Nov-18 | Market Purchase | 10,000 | $1.36 | $13,600.00 | 2% 567.14K to 577.14K | (56%) |
| 17-Aug-18 3:16 PM View: | Beaver John R EVP & Chief Financial Officer | Biolase Technology, Inc. (BIOL) | 16-Aug-18 | Market Purchase | 18,923 | $1.70 | $32,169.10 | 311% 6.08K to 25.0K | (65%) |
| 17-Aug-18 3:16 PM View: | Beaver John R EVP & Chief Financial Officer | Biolase Technology, Inc. (BIOL) | 15-Aug-18 | Market Purchase | 6,077 | $1.58 | $9,601.66 | 100% 0 to 6.08K | (62%) |
| 14-Aug-18 6:29 PM View: | Lord Jonathan T Md Director | Biolase Technology, Inc. (BIOL) | 14-Aug-18 | Market Purchase | 30,598 | $1.45 | $44,367.10 | 6% 536.55K to 567.14K | (59%) |
| 14-Aug-18 6:13 PM View: | Sato Garrett Director | Biolase Technology, Inc. (BIOL) | 10-Aug-18 | Market Purchase | 5,000 | $1.37 | $6,850.00 | 100% 0 to 5.0K | (57%) |
| 14-Aug-18 6:29 PM View: | Lord Jonathan T Md Director | Biolase Technology, Inc. (BIOL) | 10-Aug-18 | Market Purchase | 69,402 | $1.25 | $86,752.50 | 15% 467.14K to 536.55K | (53%) |
| 14-May-18 5:49 PM View: | Lord Jonathan T Md Director | Biolase Technology, Inc. (BIOL) | 11-May-18 | Option Exercise | 7,042 | -- | -- | 8% 93.43K to 100.47K | |
| 14-May-18 5:48 PM View: | Talevich James R Director | Biolase Technology, Inc. (BIOL) | 11-May-18 | Option Exercise | 7,394 | -- | -- | 57% 12.98K to 20.37K | |
| 06-Dec-17 4:33 PM View: | Feinberg Larry N 10% Owner | Biolase Technology, Inc. (BIOL) | 05-Dec-17 | Market Purchase | 10,745,600 | $0.46 | $4,900,000.00 | 53% 20.12M to 30.87M | (71%) |
